The results suggested the same conclusion that S100A6 (P=2.31E − 04, Figure 6(a)), S100A10 (P=7.36E − 04, Figure 6(b)), S100A16 (P=0.004, Figure 6(c)), and SDC1 (P=9.51E − 11, Figure 6(d)) were higher expressed in PAAD tissues compared with normal samples. Here, S100A6 is linked to pancreatic adenocarcinoma.